Patients with fistulizing Crohn's disease who have a response to induction therapy with infliximab have an increased likelihood of a sustained response over a 54-week period if infliximab ...

The Food and Drug Administration (FDA) has granted the stem cell therapy Cx601 (TiGenix) orphan drug designation for the treatment of complex perianal fistulas in patients with Crohn’s disease.

Patients with Crohn's disease are faced with a lifetime of recurrent flareups and remission, with a majority progressing from inflammatory to complicated fistulizing or penetrating disease over time.

She had a 10-year history of Crohn's colitis, perirectal abscesses and fistulizing disease, and had undergone a diverting ileostomy 16 months earlier; however, she was not on any medication for ...

A patient is reported with intestinal tuberculosis that mimicked fistulizing Crohn's disease endoscopically. He had complete resolution of symptoms after a full course of antituberculosis therapy.

24 Infliximab is also effective in the treatment of fistulizing Crohn's disease. 15,31 In addition, small studies have suggested that early treatment with infliximab or adalimumab (within 4 weeks ...

Crohn's disease is part of a group of conditions known as inflammatory bowel diseases (IBDs). There are five main types of Crohn's disease, each with its own set of symptoms. Doctors define each ...

A breakdown of Crohn’s disease, its symptoms, causes, and long-term impact on health. Explore the causes, symptoms, diagnosis, and complications.

Now they're studying stem cells as a possible treatment for autoimmune conditions like Crohn's disease. Why Use Stem Cells to Treat Crohn's Disease? Crohn's disease is a type of inflammatory bowel ...